Creo Medical is progressing its three-part strategy which will see the company continue to commercialise its core portfolio of products, acquire complementary businesses (both distribution and technology) and partner its platforms with third-party medical device developers. To support this strategy the company has announced its has conditionally raised c£31m (gross) via an equity placing with an open offer available to raise up to £5m. We continue to see significant market opportunities for Creo ....